Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
US9244059B2 · kind B2 · utility
29Cited by
1References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 25, 2010 |
| Grant date | Jan 26, 2016 |
| Priority date | — |
| Expiry date | Nov 20, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70503
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cytotoxic anti-LAG-3 monoclonal antibodies or fragments thereof causing depletion of LAG-3+ activated T cells are described, as are related pharmaceuticals and methods of treating. Also described are related nucleic acid and protein sequences.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.